Signorovitch, James E.; Wu, Eric Q.; Yu, Andrew P.; … - In: PharmacoEconomics 28 (2010) 10, pp. 935-945
The absence of head-to-head trials is a common challenge in comparative effectiveness research and health technology assessment. Indirect cross-trial treatment comparisons are possible, but can be biased by cross-trial differences in patient characteristics. Using only published aggregate data,...